Cutler Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,300
| Closed | -$196K | – | 2679 |
|
|
2022
Q3 | $196K | Sell |
1,300
-7,800
| -86% | -$1.18M | 0.01% | 480 |
|
|
2022
Q2 | $1.33M | Buy |
9,100
+4,196
| +86% | +$611K | 0.09% | 142 |
|
|
2022
Q1 | $581K | Buy |
4,904
+2,996
| +157% | +$355K | 0.03% | 338 |
|
|
2021
Q4 | $262K | Buy |
1,908
+916
| +92% | +$126K | 0.01% | 587 |
|
|
2021
Q3 | $137K | Buy |
+992
| New | +$137K | 0.01% | 835 |
|
|
2021
Q2 | – | Sell |
-1,769
| Closed | -$120K | – | 3027 |
|
|
2021
Q1 | $120K | Sell |
1,769
-3,943
| -69% | -$267K | 0.01% | 836 |
|
|
2020
Q4 | $489K | Buy |
5,712
+2,947
| +107% | +$252K | 0.02% | 356 |
|
|
2020
Q3 | $179K | Buy |
+2,765
| New | +$179K | 0.01% | 510 |
|
|
2020
Q2 | – | Sell |
-4,762
| Closed | -$162K | – | 2393 |
|
|
2020
Q1 | $162K | Sell |
4,762
-3,889
| -45% | -$132K | 0.01% | 486 |
|
|
2019
Q4 | $470K | Sell |
8,651
-791
| -8% | -$43K | 0.03% | 321 |
|
|
2019
Q3 | $393K | Sell |
9,442
-5,884
| -38% | -$245K | 0.04% | 275 |
|
|
2019
Q2 | $671K | Buy |
15,326
+14,826
| +2,965% | +$649K | 0.06% | 207 |
|
|
2019
Q1 | $25K | Buy |
+500
| New | +$25K | ﹤0.01% | 1005 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$3K | – | 2525 |
|
|
2018
Q3 | $3K | Sell |
100
-200
| -67% | -$6K | ﹤0.01% | 1467 |
|
|
2018
Q2 | $11K | Sell |
300
-4,759
| -94% | -$174K | ﹤0.01% | 1292 |
|
|
2018
Q1 | $130K | Buy |
+5,059
| New | +$130K | 0.01% | 651 |
|